Persistent URL of this record https://hdl.handle.net/1887/3184854
Documents
-
- Download
- cancers-12-03322-v2_oe1oe
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Epithelial transfer of the tyrosine kinase inhibitors Erlotinib, Gefitinib, Afatinib, Crizotinib, Sorafenib, Sunitinib, and Dasatinib: implications for clinical resistance
- All authors
- Honeywell, R.J.; Kathmann, I.; Giovannetti, E.; Tibaldi, C.; Smit, E.F.; Rovithi, M.N.; Verheul, H.M.W.; Peters, G.J.
- Date
- 2020-11-01
- Journal
- Cancers
- Volume
- 12
- Issue
- 11